Activation and differentiation of cognate T cells by a dextran‐based antigen‐presenting system for cancer immunotherapy
European Journal of Immunology · 2023
DOI: 10.1002/eji.202350528 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2023. Verfasst von Dhrubajyoti Mahata und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, India. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Science and Engineering Research Board, Department of Science and Technology, Govt. of India.
Abstract (Originalsprache)
Immunotherapeutic modulation of antigen‐specific T‐cell responses instead of the whole repertoire helps avoid immune‐related adverse events. We have developed an artificial antigen‐presenting system (aAPS) where multiple copies of a multimeric peptide‐MHC class I complex presenting a murine class I MHC restricted ovalbumin‐derived peptide (signal 1), along with a costimulatory ligand (signal 2) are chemically conjugated to a dextran backbone. Cognate naive CD8 + T cells, when treated with this aAPS underwent significant expansion and showed an activated phenotype. Furthermore, elevated expression of effector cytokines led to the differentiation of these cells to cytotoxic T lymphocytes which resulted in target cell lysis, indicative of the functional efficacy of the aAPS. CD8 + T cells with decreased proliferative potential due to repeated antigenic stimulation could also be re‐expanded by the developed aAPS. Thus, the developed aAPS warrants further engineering for future application as a rapidly customizable personalized immunotherapeutic agent, incorporating patient‐specific MHC‐restricted tumor antigens and different costimulatory signals to modulate both naive and antigen‐experienced but exhausted tumor‐specific T cells in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, India.
- School of Bioscience, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, India.
- Department of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, India.
- Department of Chemical Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, West Bengal, India.
ORCID-Profile: Dhrubajyoti Mahata, Shyam Basak
Förderung
- Science and Engineering Research Board, Department of Science and Technology, Govt. of India
Zitieren
APA
Mahata, D., Mukherjee, D., Biswas, D., Basak, S., Basak, A. J., Jamir, I., Pandey, N., Khatoon, H., Samanta, D., Basak, A., & Mukherjee, G. (2023). Activation and differentiation of cognate T cells by a dextran‐based antigen‐presenting system for cancer immunotherapy. European Journal of Immunology. https://doi.org/10.1002/eji.202350528
Vancouver
Mahata D, Mukherjee D, Biswas D, Basak S, Basak AJ, Jamir I, et al. Activation and differentiation of cognate T cells by a dextran‐based antigen‐presenting system for cancer immunotherapy. European Journal of Immunology. 2023. doi:10.1002/eji.202350528
BibTeX
@article{Mahata2023,
author = {Mahata, Dhrubajyoti and Mukherjee, Debangshu and Biswas, Debarati and Basak, Shyam and Basak, Aditya Jyoti and Jamir, Imlilong and Pandey, Nidhi and Khatoon, Huma and Samanta, Dibyendu and Basak, Amit and Mukherjee, Gayatri},
title = {Activation and differentiation of cognate T cells by a dextran‐based antigen‐presenting system for cancer immunotherapy},
journal = {European Journal of Immunology},
year = {2023},
doi = {10.1002/eji.202350528}
}
EUVIMED